 |
 |

Alendronate and Naproxen Are Synergistic for Development of Gastric Ulcers
David Y. Graham, MD;
Hoda M. Malaty, MD, PhD
Arch Intern Med. 2001;161:107-110.
Background Both alendronate sodium use and nonsteroidal anti-inflammatory drug
use are associated with gastric ulcers. The aim of this study was to investigate
whether alendronate and naproxen are synergistic as causes of gastric ulcers.
Methods We performed an endoscopist-blind, randomized, crossover, single-center
comparison of 10 mg/d of alendronate sodium, 500 mg of naproxen sodium twice
daily, or the combination taken orally for 10 days in volunteers aged 30 years
or older. Videoendoscopy was used to evaluate the presence and degree of mucosal
damage to the esophagus, stomach, or duodenal bulb before and after each treatment.
There was a 1- to 4-week washout between evaluations.
Results Twenty-six healthy volunteers participated (18 women and 8 men), aged
30 to 50 years. Gastric ulcers were present in 2 subjects receiving alendronate
(8%), in 3 receiving naproxen (12%), and in 10 receiving both (38%) (P<.05 for the combination vs either drug alone).
Conclusions Both alendronate and naproxen can cause gastric ulcers. The combination
appears synergistic. Alendronate should be used with caution in those who
simultaneously require nonsteroidal anti-inflammatory drugs.
From the Department of Medicine, Veterans Affairs Medical Center and
Baylor College of Medicine, Houston, Tex.
Corresponding author and reprints: David Y. Graham, MD, Veterans
Affairs Medical Center (111D), 2002 Holcombe Blvd, Houston, TX 77030.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
Riechelmann et al.
JNCI J Natl Cancer Inst 2007;99:592-600.
ABSTRACT
| FULL TEXT
Upper Gastrointestinal Tract Safety of Daily Oral Risedronate in Patients Taking NSAIDs: A Randomized, Double-Blind, Placebo-Controlled Trial
Adami et al.
Mayo Clin Proc. 2005;80:1278-1285.
ABSTRACT
Oral Bisphosphonates and Upper Gastrointestinal Tract Problems: What Is the Evidence?
Cryer and Bauer
Mayo Clin Proc. 2002;77:1031-1043.
ABSTRACT
Upper Gastrointestinal Tract Safety of Risedronate: A Pooled Analysis of 9 Clinical Trials
Taggart et al.
Mayo Clin Proc. 2002;77:262-270.
ABSTRACT
Alendronate and Naproxen Together Increase Risk for Gastric Ulcers
JWatch Women's Health 2001;2001:5-5.
FULL TEXT
|